Review of new oral anticoagulants

Lindsay Frye, Heather Katz, Natasha Bray, Barry Berman

Research output: Contribution to journalReview articlepeer-review


New oral anticoagulants have been developed over the past several years. These include the factor Xa inhibitors and direct thrombin inhibitors. These anticoagulants have been tested for safety and efficacy against standard therapies including subcutaneous enoxaparin or oral warfarin. The following is a review of pertinent trials comparing the new oral anticoagulants to standard therapy.

Original languageEnglish
Pages (from-to)8-15
Number of pages8
JournalOsteopathic Family Physician
Issue number3
StatePublished - 1 May 2015


  • Anticoagulation
  • Atrial fibrillation
  • Deep vein thrombosis
  • Pulmonary embolus
  • Warfarin


Dive into the research topics of 'Review of new oral anticoagulants'. Together they form a unique fingerprint.

Cite this